...GBL. UBS Warburg was financial advisor to BMRN. BioMarin Pharmaceutical Inc. (BMRN; SWX:BMRN), Novato, Calif. Glyko...

...11.4 million new BMRN shares to GBL stockholders. BioMarin Pharmaceutical Inc. (BMRN; SWX:BMRN), Novato, Calif. Glyko...

...Management, B9) Glyko BioMedical Ltd. (TSE:GBL; GLYK), Toronto, Ontario Business: Supply/Service Appointed: Joerg Gruber, chairman of...

...Board, B8) Glyko BioMedical Ltd. (TSE:GBL; GLYK), Toronto, Ontario Business: Supply/Service Hired: Erich Sager as president...

...bought the biochemical reagent product line of Oxford GlycoScience (UK) Ltd., a subsidiary of OGS. Glyko...

...BioMarin acquired GLYK subsidiary Glyko Inc. , a provider of carbohydrate enzyme analytical and diagnostic products, for...
...by BioMarin. The deal brings GLYK's ownership of BioMarin to 41.7 percent from 38 percent. Glyko Inc....
...Cambridge, Mass). Glyko will operate as a subsidiary of BioMarin. BioMarin Pharmaceutical Inc., Novato, Calif. Glyko...

...Inc. (NTEC, Horsham, Penn.), Cytel Corp. (CYTL, San Diego, Calif.), Biomira Inc. (BIOMF, Edmonton, Alberta), Glyko...

...to diagnose and monitor the progression of prostate cancer based on the company's FACE technology. Glyko...